Hohlfeld Konrad, Wegner Jörg Kurt, Kesteleyn Bart, Linclau Bruno, Unge Johan
†University of Southampton, School of Chemistry, Highfield, Southampton SO17 1BJ, United Kingdom.
‡Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
J Med Chem. 2015 May 14;58(9):4029-38. doi: 10.1021/acs.jmedchem.5b00358. Epub 2015 Apr 30.
A series of darunavir analogues featuring a substituted bis-THF ring as P2 ligand have been synthesized and evaluated. Very high affinity protease inhibitors (PIs) with an interesting activity on wild-type HIV and a panel of multi-PI resistant HIV-1 mutants containing clinically observed, primary mutations were identified using a cell-based assay. Crystal structure analysis was conducted on a number of PI analogues in complex with HIV-1 protease.
已合成并评估了一系列以取代双四氢呋喃环作为P2配体的地瑞那韦类似物。使用基于细胞的检测方法，鉴定出了对野生型HIV以及一系列含有临床观察到的原发性突变的多蛋白酶抑制剂耐药HIV-1突变体具有有趣活性的高亲和力蛋白酶抑制剂（PI）。对许多与HIV-1蛋白酶复合的PI类似物进行了晶体结构分析。
